股腘动脉开放与腔内血运重建治疗慢性肢体威胁性缺血的结局比较
这项前瞻性观察性队列研究纳入190例慢性肢体威胁性缺血(CLTI)患者,比较股腘动脉段腔内介入(n=117)与旁路手术(n=73)的2年结局。
核心结论
- 2年随访时,旁路手术与更高的无截肢生存率相关,且不能仅用病例组合差异解释。
- 旁路手术后更多患者在1年和2年时免于CLTI症状。
- 维持通畅的再干预在旁路手术和腔内介入后同样常见。
研究设计与样本
- 前瞻性观察性队列研究,2011年3月至2015年1月纳入190例CLTI患者。
- 主要靶病变位于股浅动脉或腘动脉段,接受腔内介入(n=117)或旁路手术(n=73)。
- 血运重建技术选择基于国际和当地指南,所有患者随访2年。
主要发现
- Kaplan-Meier分析证实AFS组间显著差异,死亡率是主要驱动因素。
- 多变量回归分析中,AFS差异仍 favoring 旁路手术(HR 2.38,95%CI 1.14-4.96)。
临床怎么用
- 在CLTI股腘动脉病变血运重建决策中,旁路手术可能提供更好的2年无截肢生存和症状缓解。
- 腔内介入仍可选,但需权衡其较低的AFS和症状缓解率与旁路手术的重复再干预风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal strategy for revascularization in chronic limb-threatening ischemia (CLTI) is not yet completely known and is still under debate. Endovascular treatment methods predominate despite limited evidence for their advantage. In this concurrent, prospective observational cohort study, we investigated outcomes after open and endovascular revascularization in the femoropopliteal segment for CLTI. METHODS: Between March 2011 and January 2015, there were 190 patients presenting with CLTI with the principal target lesion in the superficial femoral or popliteal segment who underwent endovascular intervention (n = 117) or bypass surgery (n = 73) and were observed prospectively. The choice of revascularization technique was based on international and local guidelines. All patients were observed for 2 years. The primary end point was amputation-free survival (AFS) assessed with Kaplan-Meier estimates; secondary end points included CLTI symptom alleviation rates and reintervention rates. A Cox proportional hazards regression model was used to investigate risk factors for amputation and death. RESULTS: AFS at 2 years was 59% in the endovascular group and 76% in the bypass group (P = .020). Kaplan-Meier survival analysis confirmed a significant difference in AFS, with mortality rate as the main driver for the observed intergroup AFS difference. In sequential multivariable regression analysis, the observed difference in AFS between the groups favored bypass surgery and remained significant after controlling for covariates of known prognostic importance (hazard ratio, 2.38; 95% confidence interval, 1.14-4.96). At 2 years, a higher proportion of patients subjected to bypass surgery remained free from ischemic rest pain, wounds, and gangrene (65% vs 45%; P = .009). The proportions of patients who underwent reintervention within 2 years were similar in the two groups (38% vs 39%; P = .90), but repeated reinterventions were more frequent in the bypass group. CONCLUSIONS: At 2 years, bypass surgery was associated with higher AFS than endovascular intervention, a finding that could not be explained only by differences in case mix. More patients who had bypass surgery were free from CLTI symptoms at both 1 year and 2 years after revascularization. Reinterventions to maintain patency were equally common after bypass and endovascular intervention.
引用
- Perlander A, Jivegård L, Nordanstig J, et al. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia. J Vasc Surg. 2020. PMID: 32276010. doi:10.1016/j.jvs.2020.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。